title: Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A.
authors.affiliation: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands.
authors.forename: J G
authors.initials: JG
authors.lastname: van der Bom
authors.forename: S C
authors.initials: SC
authors.lastname: Gouw
authors.forename: F R
authors.initials: FR
authors.lastname: Rosendaal
mesh_terms: D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007518:Isoantibodies / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology* / Q000627:therapeutic use
chemical_list: D007518:Isoantibodies; D011994:Recombinant Proteins; D005169:Factor VIII